ATE510550T1 - Verfahren zur reduzierung von beta-amyloid- polypeptiden - Google Patents

Verfahren zur reduzierung von beta-amyloid- polypeptiden

Info

Publication number
ATE510550T1
ATE510550T1 AT02723408T AT02723408T ATE510550T1 AT E510550 T1 ATE510550 T1 AT E510550T1 AT 02723408 T AT02723408 T AT 02723408T AT 02723408 T AT02723408 T AT 02723408T AT E510550 T1 ATE510550 T1 AT E510550T1
Authority
AT
Austria
Prior art keywords
reducing beta
amyloid polypeptides
cimicifuga
extract
amyloid
Prior art date
Application number
AT02723408T
Other languages
English (en)
Inventor
Christopher B Eckman
Debra Yager
Sharie Haugabook
Abdul Fauq
Original Assignee
Mayo Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation filed Critical Mayo Foundation
Application granted granted Critical
Publication of ATE510550T1 publication Critical patent/ATE510550T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT02723408T 2001-03-12 2002-03-12 Verfahren zur reduzierung von beta-amyloid- polypeptiden ATE510550T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/804,420 US6649196B2 (en) 2001-03-12 2001-03-12 Methods of reducing β-amyloid polypeptides
PCT/US2002/007515 WO2002072125A1 (en) 2001-03-12 2002-03-12 Methods of reducing beta-amyloid polypeptides

Publications (1)

Publication Number Publication Date
ATE510550T1 true ATE510550T1 (de) 2011-06-15

Family

ID=25188933

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02723408T ATE510550T1 (de) 2001-03-12 2002-03-12 Verfahren zur reduzierung von beta-amyloid- polypeptiden

Country Status (5)

Country Link
US (4) US6649196B2 (de)
EP (2) EP2298329A1 (de)
AT (1) ATE510550T1 (de)
ES (1) ES2367895T3 (de)
WO (1) WO2002072125A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2848445C (en) 2004-09-14 2016-10-25 Edwards Lifesciences Ag Device and method for treatment of heart valve regurgitation
AU2006206591B2 (en) 2005-01-21 2011-08-25 Mayo Foundation For Medical Education And Research Thorascopic heart valve repair method and apparatus
US20060210659A1 (en) * 2005-03-16 2006-09-21 Asahi Breweries, Ltd. Anti-obesity agent
US20070149491A1 (en) * 2005-05-17 2007-06-28 Findeis Mark A Compounds useful for treating neurodegenerative disorders
CA2609021C (en) * 2005-05-17 2013-07-09 Satori Pharmaceuticals, Inc. Compounds useful for treating neurodegenerative disorders
KR20070091928A (ko) * 2006-03-08 2007-09-12 주식회사 엠웰 승마 추출물을 함유하는 뇌신경 질환의 예방 또는 치료용조성물
JP5379692B2 (ja) 2006-11-09 2013-12-25 プロビオドルグ エージー 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての３−ヒドロキシ−１，５−ジヒドロ−ピロール−２−オン誘導体
EP2083621A4 (de) * 2006-11-20 2010-03-24 Satori Pharmaceuticals Inc Modulatoren der amyloid-beta-produktion
EP2073638B1 (de) * 2006-11-20 2013-05-15 Satori Pharmaceuticals, Inc. Synthese von verbindungen als modulatoren der amyloid-beta-produktion
EP2091948B1 (de) 2006-11-30 2012-04-18 Probiodrug AG Neue inhibitoren von glutaminylcyclase
CA2679446C (en) 2007-03-01 2016-05-17 Probiodrug Ag New use of glutaminyl cyclase inhibitors
US9656991B2 (en) 2007-04-18 2017-05-23 Probiodrug Ag Inhibitors of glutaminyl cyclase
WO2009052528A2 (en) 2007-10-18 2009-04-23 Neochord Inc. Minimially invasive repair of a valve leaflet in a beating heart
BR112012008346B1 (pt) 2009-09-11 2021-12-21 Vivoryon Therapeutics N.V. Derivados heterocíclicos, seu processo de preparação, e composição farmacêutica
WO2011107530A2 (en) 2010-03-03 2011-09-09 Probiodrug Ag Novel inhibitors
DK2545047T3 (da) 2010-03-10 2014-07-28 Probiodrug Ag Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5)
EP2560953B1 (de) 2010-04-21 2016-01-06 Probiodrug AG Hemmer der glutaminylzyklase
US9044221B2 (en) 2010-12-29 2015-06-02 Neochord, Inc. Exchangeable system for minimally invasive beating heart repair of heart valve leaflets
WO2012123563A1 (en) 2011-03-16 2012-09-20 Probiodrug Ag Benz imidazole derivatives as inhibitors of glutaminyl cyclase
WO2012167120A2 (en) 2011-06-01 2012-12-06 Neochord, Inc. Minimally invasive repair of heart valve leaflets
WO2017059406A1 (en) 2015-10-01 2017-04-06 Neochord, Inc. Ringless web for repair of heart valves
US10213306B2 (en) 2017-03-31 2019-02-26 Neochord, Inc. Minimally invasive heart valve repair in a beating heart
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej
CA3094990C (en) 2018-03-23 2023-01-03 Neochord, Inc. Device for suture attachment for minimally invasive heart valve repair
US11173030B2 (en) 2018-05-09 2021-11-16 Neochord, Inc. Suture length adjustment for minimally invasive heart valve repair
US11253360B2 (en) 2018-05-09 2022-02-22 Neochord, Inc. Low profile tissue anchor for minimally invasive heart valve repair
CN113194854A (zh) 2018-09-07 2021-07-30 尼奥绰德有限公司 用于微创心脏瓣膜修复的缝线附接装置
CN114206265A (zh) 2019-04-16 2022-03-18 尼奥绰德有限公司 用于微创心脏瓣膜修复的横向螺旋心脏锚固器
US12208007B2 (en) 2020-01-16 2025-01-28 Neochord, Inc. Helical cardiac anchors for minimally invasive heart valve repair

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3070086D1 (en) * 1979-12-03 1985-03-14 Kitasato Inst A process for preparing substances having interferon inducing activity
JPS5920298A (ja) 1982-07-21 1984-02-01 Suntory Ltd 新規トリテルペン配糖体
US4666829A (en) 1985-05-15 1987-05-19 University Of California Polypeptide marker for Alzheimer's disease and its use for diagnosis
KR930000059B1 (ko) * 1990-04-24 1993-01-08 태평양화학 주식회사 충치를 예방하기 위한 구강용 조성물
KR940002170B1 (ko) 1991-06-05 1994-03-18 순흥화학공업 주식회사 전투화 굽 및 그 제조방법
US5538845A (en) 1992-02-05 1996-07-23 Athena Neurosciences, Inc. Beta-amyloid peptide production inhibitors and methods for their identification
US5604102A (en) 1992-04-15 1997-02-18 Athena Neurosciences, Inc. Methods of screening for β-amyloid peptide production inhibitors
US5766846A (en) 1992-07-10 1998-06-16 Athena Neurosciences Methods of screening for compounds which inhibit soluble β-amyloid peptide production
US5552426A (en) 1994-04-29 1996-09-03 Eli Lilly And Company Methods for treating a physiological disorder associated with β-amyloid peptide
JPH0930977A (ja) 1995-07-20 1997-02-04 Tsuneo Nanba 升麻抽出物を含有する骨疾患治療剤
JPH0931094A (ja) * 1995-07-20 1997-02-04 Tsuneo Nanba 升麻中に含有されるテルペン化合物
US5916565A (en) * 1996-03-08 1999-06-29 In Clover, Inc. Product and method for treating joint disorders in vertebrates
US5703129A (en) 1996-09-30 1997-12-30 Bristol-Myers Squibb Company 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of β-amyloid protein production
US6096782A (en) 1996-11-22 2000-08-01 Athena Neurosciences, Inc. N-(aryl/heteroaryl) amino acid derivatives pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6191166B1 (en) 1997-11-21 2001-02-20 Elan Pharmaceuticals, Inc. Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis
US6211235B1 (en) 1996-11-22 2001-04-03 Elan Pharmaceuticals, Inc. Compounds for inhibiting β-amyloid peptide release and/or its synthesis

Also Published As

Publication number Publication date
EP1372684B1 (de) 2011-05-25
US20080299229A1 (en) 2008-12-04
US20060127509A1 (en) 2006-06-15
US20040071802A1 (en) 2004-04-15
ES2367895T3 (es) 2011-11-10
US7300677B2 (en) 2007-11-27
EP1372684A1 (de) 2004-01-02
US6649196B2 (en) 2003-11-18
EP2298329A1 (de) 2011-03-23
EP1372684A4 (de) 2005-06-08
US20020127290A1 (en) 2002-09-12
WO2002072125A1 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
ATE510550T1 (de) Verfahren zur reduzierung von beta-amyloid- polypeptiden
BR0012759A (pt) Neurotoxinas recombinantes ativáveis
ATE520466T1 (de) Apparat und verfahren zur modifizierung von magnetisch inmmobilizierte biomolekulen
DK1133558T3 (da) Sammensætninger og fremgangsmåder til forögelse af knoglemineralisering
ATE392430T1 (de) Verfahren zur herstellung von dipeptiden
DE3880703D1 (de) Verfahren zur stabilisationsbehandlung von ferromagnetischen metallpulvern.
ATE334136T1 (de) Verfahren zur herstellung von azithromycin
ATE296123T1 (de) Verfahren zur herstellung bioaktiver implantatoberflächen
DE60134718D1 (de) Vorrichtung und Verfahren zur Kontrolle von fokussierten Elektronenstrahlen
ATE309353T1 (de) Verfahren zur herstellung von rekombinanten peptiden
DE3587875D1 (de) Rekombinantverfahren zur herstellung von serinproteaseinhibitoren, sowie dns-sequenzen dazu.
DE69326559D1 (de) Rekombinante methode und wirt zur herstellung von xylitol
DE60230456D1 (de) Faktor-viii-polypeptide auf hohem expressionsnivea und verwendungsverfahren
ATE255380T1 (de) Verfahren zur herstellung von prothesen
DK1109571T3 (da) Fremgangsmåde til behandling af saltafhængig hypertension
NO20073914L (no) Biologisk aktive peptider
ATE361334T1 (de) Verfahren zur herstellung von hochreinem polycarbonat
DE60124289D1 (de) Verfahren zur herstellung von 21-hydroxy-6,19-oxidoprogesteron (21oh-6op)
ATE181549T1 (de) Verfahren zur herstellung von (s)-3-amino-1- substituiert-pirrolidine
DE69001485D1 (de) Verfahren zur gasphasen-herstellung von diamant.
DE60201212D1 (de) Verfahren zur Herstellung von Stickstofftrifluorid
DE60029456D1 (de) Verfahren zur Online-Anpassung von Aussprachewörterbüchern
DE69332973D1 (de) Verfahren zur herstellung von gesinterterm erz
DE3667960D1 (de) Verfahren zur herstellung von halogen-magnesium-alanat und dessen verwendung.
DE69738985D1 (de) Raffinosesynthetase gen, verfahren zur herstellung von raffinose und transformierte pflanze

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties